The Cardiovascular Impact of Carfilzomib in Multiple Myeloma

被引：0
|
作者：
Rosenthal, Allison C. [1 ]
Luthi, Jennifer [1 ]
Belohlavek, Marek [1 ]
Mookadam, Farouk [1 ]
Mayo, Angela [1 ]
Fonseca, Rafael [1 ,2 ]
Bergsagel, P. Leif
Reeder, Craig B. [1 ]
Mikhael, Joseph R. [1 ]
Stewart, Keith [2 ]
机构：
[1] Mayo Clin Arizona, Scottsdale, AZ USA
[2] Mayo Clin, Scottsdale, AZ USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Carfilzomib in combination with daratumumab in the management of relapsed multiple myeloma
    Touzeau, Cyrille
    Antier, Chloe
    Moreau, Philippe
    FUTURE ONCOLOGY, 2021, 17 (09) : 993 - 998
  • [42] Discovery and development of carfilzomib (CFZ) for multiple myeloma (MM)
    Wang, Zhengping
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [43] Carfilzomib boosted combination therapy for relapsed multiple myeloma
    Steiner, Raphael E.
    Manasanch, Elisabet E.
    ONCOTARGETS AND THERAPY, 2017, 10 : 895 - 907
  • [44] Cardiac and renal complications of carfilzomib in patients with multiple myeloma
    Dimopoulos, Meletios A.
    Roussou, Maria
    Gavriatopoulou, Maria
    Psimenou, Erasmia
    Ziogas, Dimitrios
    Eleutherakis-Papaiakovou, Evangelos
    Fotiou, Despina
    Migkou, Magdalini
    Kanellias, Nikolaos
    Panagiotidis, Ioannis
    Ntalianis, Argyrios
    Papadopoulou, Elektra
    Stamatelopoulos, Kimon
    Manios, Efstathios
    Pamboukas, Constantinos
    Kontogiannis, Sofoklis
    Terpos, Evangelos
    Kastritis, Efstathios
    BLOOD ADVANCES, 2017, 1 (07) : 449 - 454
  • [45] Carfilzomib therapy improves quality of life in multiple myeloma
    Das, Manjulika
    LANCET ONCOLOGY, 2016, 17 (10): : E427 - E427
  • [46] Carfilzomib for the treatment of patients with relapsed and/or refractory multiple myeloma
    Stewart, A. Keith
    FUTURE ONCOLOGY, 2015, 11 (15) : 2121 - 2136
  • [47] Clinical impact of time to the best response in relapsed/refractory multiple myeloma patients receiving carfilzomib
    Cho, Hee Jeong
    Moon, Joon Ho
    Kim, Ju-Hyung
    Baek, Dong Won
    Sohn, Sang-Kyun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S166 - S166
  • [48] Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients
    Cristina Gasparetto
    Gary J. Schiller
    Sascha A. Tuchman
    Natalie S. Callander
    Muhamed Baljevic
    Suzanne Lentzsch
    Adriana C. Rossi
    Rami Kotb
    Darrell White
    Nizar J. Bahlis
    Christine I. Chen
    Heather J. Sutherland
    Sumit Madan
    Richard LeBlanc
    Michael Sebag
    Christopher P. Venner
    William I. Bensinger
    Noa Biran
    Sonia Ammu
    Osnat Ben-Shahar
    Andrew DeCastro
    Dane Van Domelen
    Tianjun Zhou
    Chris Zhang
    Ohad S. Bentur
    Jatin Shah
    Sharon Shacham
    Michael Kauffman
    Brea Lipe
    British Journal of Cancer, 2022, 126 : 718 - 725
  • [49] Longitudinal changes in echocardiographic variables and endothelial function to predict cardiovascular toxicities in patients with multiple myeloma receiving carfilzomib
    Johnston, Hannah
    Prabhu, Nicole
    Cunningham, Claire
    Cooperrider, Jennifer H.
    Andreatos, Evangelia
    Gorski, Martha
    Major, Sarah
    Wolfe, Brittany
    Kruse, Eric
    Derman, Benjamin Avi
    Lang, Roberto
    Jakubowiak, Andrzej
    Major, Ajay
    DeCara, Jeanne
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients
    Gasparetto, Cristina
    Schiller, Gary J.
    Tuchman, Sascha A.
    Callander, Natalie S.
    Baljevic, Muhamed
    Lentzsch, Suzanne
    Rossi, Adriana C.
    Kotb, Rami
    White, Darrell
    Bahlis, Nizar J.
    Chen, Christine, I
    Sutherland, Heather J.
    Madan, Sumit
    LeBlanc, Richard
    Sebag, Michael
    Venner, Christopher P.
    Bensinger, William, I
    Biran, Noa
    Ammu, Sonia
    Ben-Shahar, Osnat
    DeCastro, Andrew
    Van Domelen, Dane
    Zhou, Tianjun
    Zhang, Chris
    Bentur, Ohad S.
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael
    Lipe, Brea
    BRITISH JOURNAL OF CANCER, 2022, 126 (05) : 718 - 725
12345